10
Participants
Start Date
October 16, 2013
Primary Completion Date
October 16, 2025
Study Completion Date
October 16, 2025
Allogenic Human Islet Cells
Intraportal (into the liver) infusion of islet cells, with a maximum of three islet transplants.
Immunosuppressive Agents
Anti-rejection medications (to prevent the body from rejecting the islet cells) and other medications to guard against infection and support participant health and/or the health of the transplanted islets.
Gastrin 17
Gastrin-17 (or GAST-17) - a gut hormone injected under the skin for 30 days (optional treatment for islet dysfunction).
City of Hope Medical Center, Duarte
University of California, Los Angeles
OTHER
City of Hope Medical Center
OTHER